Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq...

NASDAQ Grants Eightco’s Request for Continued Listing on The Nasdaq Capital Market Continued listing is subject to meeting certain conditions by August 23, 2024 including maintaining a minimum bid price of $1.00 or more for a minimum of ten consecutive trading sessions ...